Joint Crisis Plan Effectiveness in Preventing Relapses in Schizophrenia and Schizoaffective Disorder
SOS
Effectiveness of a Joint Crisis Plan (SOS Plan) in Preventing Relapses in Patients Diagnosed With Schizophrenia and Schizoaffective Disorder
2 other identifiers
interventional
124
1 country
4
Brief Summary
The Joint Crisis Plan = SOS Plan is a reference to a particular form of psychiatric advance directive which involves the patient, the healthcare team, their relatives and a third party caregiver as intermediary for the project. The main objective is to evaluate the effectiveness of the SOS Plan (JCP) in terms of the reduction in hospitalisations within 18 months of its development by comparison to the standard psychiatric care. Thus, the investigators' proposal is that SOS Plan's are regularly reassessed every 6 months and again where there is an unplanned psychiatric readmission that lasts beyond two weeks. Single blind multicentre randomised trial with parallel control groups. Effectiveness study of a psychiatric care strategy.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable schizophrenia
Started Dec 2014
Shorter than P25 for not_applicable schizophrenia
4 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 5, 2014
CompletedFirst Submitted
Initial submission to the registry
July 6, 2015
CompletedFirst Posted
Study publicly available on registry
December 11, 2015
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 10, 2016
CompletedStudy Completion
Last participant's last visit for all outcomes
March 10, 2016
CompletedDecember 16, 2025
September 1, 2020
1.3 years
July 6, 2015
December 8, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
incidence of the first psychiatric hospitalisation
the incidence of the first psychiatric hospitalisation within 18 months following inclusion
18 months
Secondary Outcomes (11)
cumulative time in days of psychiatric hospitalisations
2 years
types of psychiatric hospitalisations
2 years
number of hospitalisations
2 years
number of emergency psychiatric consultations
2 years
clinical assessment by the PANSS scale
every 6 months during 2 years
- +6 more secondary outcomes
Study Arms (2)
SOS Intervention Group
EXPERIMENTALSubjects benefit from the SOS Plan in addition to the usual follow-ups
Control Group
NO INTERVENTIONSubjects receive no additional intervention (tracking the continuation of psychiatric care according to the standard care terms)
Interventions
It is a customised procedure that involves a meeting (crisis planning meeting) with the patient, their various medical and social referrers and any other person who they may have desired to invite. The booklet outlines four avenues to consider: * Contact details / contact person * Treatment and current follow-ups * Medical care in the event of a crisis * Practical aid in the event of a crisis Updating the SOS Plan every 6 months in the absence of hospitalisation or after each relapse that leads to an unscheduled psychiatric hospitalisation lasting more than two weeks.
Eligibility Criteria
You may qualify if:
- Aged between 18 and 65 years
- Diagnosed with schizophrenia or schizoaffective disorder according to criteria specified in DSM
- Psychiatric inpatient or an outpatient with a specialised framework of psychiatric follow-ups
- Patient has been hospitalised at least once in a psychiatric department within the previous 2 years
- Adults under protective measures can be included (guardianship/supervision). Consent will also be sought from the guardian or trusted person.
- Registered for social security
You may not qualify if:
- Refusal to participate in the study
- Unable to give his or her written consent
- Patients detained
- Pregnant or lactating women
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University Hospital, Lillelead
- Ministry of Health, Francecollaborator
Study Sites (4)
University Hospital, Brest
Brest, France
University Hospital, Caen
Caen, France
University Hosiptal, Lille
Lille, France
Sainte-Anne Hospital, Paris
Paris, France
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Guillaume Vaiva
University Hospiltal Lille
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 6, 2015
First Posted
December 11, 2015
Study Start
December 5, 2014
Primary Completion
March 10, 2016
Study Completion
March 10, 2016
Last Updated
December 16, 2025
Record last verified: 2020-09